Crestline Management’s Evolus EOLS Stock Holding History

Crestline Management’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,000	Closed	-$263K	–	89
2019 Q2	$263K	Buy	+18,000	New	+$357K	0.04%	80

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wafra Inc New York $5.95M AUM 6.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestline Management's EOLS Position: Q3 2019 in Review

Crestline Management sold out of Evolus (EOLS) in Q3 2019, closing a stake of 18,000 shares — an estimated $263K sold.

Crestline Management first reported a position in EOLS in Q2 2019 and held it in 1 quarter. The position peaked at $263K in Q2 2019. 95 funds tracked by Wall St. Rank hold EOLS as of Q3 2019.

Crestline Management reported no remaining Evolus position as of Q3 2019 after selling out during the quarter.
Crestline Management sold 18,000 Evolus shares in Q3 2019, an estimated $263K.
Crestline Management first reported a position in Evolus in Q2 2019 and held it in 1 quarter.
Crestline Management's Evolus position peaked at $263K in Q2 2019.
95 funds tracked by Wall St. Rank held Evolus as of Q3 2019.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.